In the current issue of the Journal of Alzheimer's Disease, a novel paper from researchers from the National Institute for Longevity Sciences, NCGG, Japan and Center for Neurological Diseases, Brigham & Women's Hospital, Harvard Institute of Medicine shows that a new oral vaccine treatment is effective in reducing Alzheimer's disease pathology.
In the current issue of the Journal of Alzheimer’s Disease, a novel paper from researchers from the National Institute for Longevity Sciences, NCGG, Japan and Center for Neurological Diseases, Brigham & Women’s Hospital, Harvard Institute of Medicine shows that a new oral vaccine treatment is effective in reducing Alzheimer’s disease pathology.
http://www.sciencedaily.com/releases/2004/10/041025132452.htm